VACCINEX
Vaccinex has developed an antibody discovery platform that enables efficient mammalian cell-based expression for expression of large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface envelope of a mammalian virus and the cell surface membrane of the infected cell. This allows them to combine the advantages of virus panning and cell sorting into one seamless selection process. This technology enables the rapid selection of 1010 antibody combinations and thus selection of high affinity leads with varied frameworks that recognize multiple epitopes. It is based in Rochester, New York.
VACCINEX
Industry:
Biotechnology Clinical Trials Health Care Oncology
Founded:
1997-01-01
Address:
Rochester, New York, United States
Country:
United States
Website Url:
http://www.vaccinex.com
Total Employee:
11+
Status:
Active
Contact:
585-271-2700
Email Addresses:
[email protected]
Total Funding:
80.7 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Tag Manager WordPress Google Analytics SSL By Default Global Site Tag IPv6
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Maurice Zauderer
Maurice Zauderer investment in Post-IPO Equity - Vaccinex
Jacob Frieberg
Jacob Frieberg investment in Post-IPO Equity - Vaccinex
Albert Friedberg
Albert Friedberg investment in Post-IPO Equity - Vaccinex
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Vaccinex
Official Site Inspections
http://www.vaccinex.com Semrush global rank: 4 M Semrush visits lastest month: 2.72 K
- Host name: 198.46.88.224
- IP address: 198.46.88.224
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "Vaccinex"
Vaccinex - LinkedIn
Vaccinex (NASDAQ: VCNX) is a clinical stage biotechnology company pioneering a differentiated approach to treating cancer and progressive neurodegenerative diseases through the inhibition of...See details»
Organization | Vaccinex Inc.
Vaccinex Inc. Report issue. For profit Phase 1 Phase 2. Founded: Rochester NY United States (2001 ... Organization Overview. First Clinical Trial. 2011 NCT01313065. First Marketed Drug. …See details»
Vaccinex - Huntington's Disease Society of America
Vaccinex, Inc. (Nasdaq: VCNX) is pioneering a differentiated approach to treating neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), a key driver of …See details»
Vaccinex Company Profile 2024: Stock Performance
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, …See details»
Vaccines and immunization - World Health …
Nov 18, 2024 · WHO is working with countries and partners to improve global vaccination coverage, including through these initiatives adopted by the World Health Assembly in August 2020. IA2030 sets an ambitious, overarching …See details»
Vaccinex, Inc. Company Profile | Rochester, NY | Competitors ...
Find company research, competitor information, contact details & financial data for Vaccinex, Inc. of Rochester, NY. Get the latest business insights from Dun & Bradstreet.See details»
Vaccinex Reports Third Quarter 2024 Financial Results and …
ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating …See details»
Vaccinex Inc, VCNX:NAQ profile - FT.com - Financial Times
3 days ago · Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and …See details»
Vaccinex, Inc. (VCNX) - Yahoo Finance
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and …See details»
Vaccinex Announces $3 Million Award from the Alzheimer’s
Dec 10, 2019 · --Vaccinex, Inc., a clinical-stage biotechnology company pioneering novel antibody therapies in neurodegenerative diseases and cancer, today announced that it has been …See details»
Vaccinex Inc, VCNX:NAQ summary - FT.com - Financial Times
Nov 20, 2024 · Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious …See details»
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain ...
Oct 10, 2023 · ROCHESTER, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach …See details»
VCNX Stock Quote Price and Forecast | CNN
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical...See details»
Vaccinex Announces Multiple New Agreements for Access to
Feb 21, 2024 · Eight new antibody discovery agreements incorporate Vaccinex’s powerful ActivMAb® Drug Discovery Platform. ActivMab® platform enables the discovery and …See details»
VCNX Stock Price Quote - Morningstar
6 days ago · See the latest Vaccinex Inc stock price (VCNX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
VCNX | Vaccinex Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical...See details»
www.vaccinex.com Perfecting in vitro mammalian display for …
To overcome these challenges, the privately held clinical-stage biotech company Vaccinex has developed a proprietary platform called ActivMAb for rapid, mammalian cell–based anti-body …See details»
Vaccinex Reports Completion of Last Patient Visit in ... - Nasdaq
ROCHESTER, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating …See details»
Vaccine: X | Journal | ScienceDirect.com by Elsevier
Vaccine: X is the open access companion journal of Vaccine and has the same aims and scope. The journal offers authors who want to publish in a gold open access journal the opportunity to …See details»